U.S. Communications Stock News

NYSE:ARR
NYSE:ARRMortgage REITs

ARMOUR Residential REIT’s Swing Back To Profit And New Dividend Might Change The Case For Investing In ARR

In February 2026, ARMOUR Residential REIT, Inc. reported full-year 2025 results showing net income of US$322.69 million and basic earnings per share from continuing operations of US$3.31, alongside declaring a US$0.24 per-share cash dividend payable on March 30, 2026 to shareholders of record on March 16, 2026. The swing from a prior-year net loss and loss per share to positive earnings highlights a material turnaround in ARMOUR Residential REIT’s profitability profile. Next, we’ll examine...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Cytokinetics (CYTK) Quarterly Loss Of US$183 Million Reinforces Bearish Profitability Concerns

Cytokinetics (CYTK) has capped FY 2025 with Q4 revenue of US$17.8 million and a basic EPS loss of US$1.52, anchored by a net loss of US$183.0 million. This sets the tone for how investors are reading the latest update against a year of heavy spending. Over recent periods, the company has seen quarterly revenue range from US$1.6 million to US$66.8 million in FY 2025, while basic EPS losses have moved between US$1.12 and US$2.55. This gives a clear picture of a business that is still investing...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Is There Now an Opportunity in Expedia Group (EXPE) After the Recent Share Price Pullback

If you are wondering whether Expedia Group's share price reflects its real worth today, you are not alone. This article will walk through what the current market price might be implying about the company. After a long term return of 93.5% over 3 years and 25.7% over 5 years, the stock has recently pulled back, with a 24.4% decline over 30 days and a 28.0% decline year to date from a last close of US$203.74. This may have shifted how the market is thinking about its future. Recent headlines...
NasdaqGS:ACHC
NasdaqGS:ACHCHealthcare

Acadia Healthcare Company (ACHC) Posts Q4 US$1.18b Loss Testing Bullish Margin Narratives

Acadia Healthcare Company (ACHC) just wrapped up FY 2025 with Q4 revenue of US$821.5 million and a basic EPS loss of US$13.02, alongside a trailing 12-month basic EPS loss of US$12.16 on revenue of about US$3.3 billion. The company has seen quarterly revenue move from US$774.2 million in Q4 2024 to US$770.5 million in Q1 2025, US$869.2 million in Q2, US$851.6 million in Q3, and US$821.5 million in Q4, while basic EPS shifted from US$0.36 in Q4 2024 to US$0.09, US$0.33, and US$0.40 through the...
NasdaqGS:RGEN
NasdaqGS:RGENLife Sciences

Assessing Repligen (RGEN) After Prolonged Share Price Weakness

If you are wondering whether Repligen's current share price lines up with its underlying worth, you are not alone. This article walks through what the numbers actually say about value. Repligen's share price closed at US$132.14, with returns of a 4.3% decline over 7 days, 19.1% decline over 30 days, 19.6% decline year to date, 18.8% decline over 1 year, 25.1% decline over 3 years, and 33.9% decline over 5 years. This may signal that expectations or perceived risk have shifted over...
NYSE:TALO
NYSE:TALOOil and Gas

Talos Energy FY 2025 Earnings Loss Deepens Bear Narratives On Profitability Path

Talos Energy FY 2025 earnings recap Talos Energy (TALO) closed out FY 2025 with fourth quarter revenue of US$392.2 million and a basic EPS loss of US$1.19, alongside a full year trailing twelve month revenue base of about US$1.8 billion and a loss of US$2.82 per share. Over recent quarters, the company has seen quarterly revenue move from US$509.1 million in Q3 2024 to US$512.9 million in Q1 2025 and then within a US$392.2 million to US$450.0 million range through Q4 2025. Basic EPS shifted...
NYSE:TPH
NYSE:TPHConsumer Durables

Tri Pointe Homes (TPH) Margin Compression Reinforces Bearish Earnings Narrative

Tri Pointe Homes (TPH) just posted its FY 2025 numbers with fourth quarter revenue of US$972.6 million and basic EPS of US$0.71, alongside full year trailing twelve month revenue of US$3.5 billion and EPS of US$2.73. Over the past six quarters, revenue has moved from US$1.25 billion in Q4 2024 to US$972.6 million in Q4 2025, while quarterly EPS shifted from US$1.39 to US$0.71. Investors now have to weigh these results against a trailing net margin that sits at 6.9% compared with 10.2% a year...
NYSEAM:INFU
NYSEAM:INFUHealthcare

InfuSystem Holdings (INFU) Margin Gains Reinforce Bullish Narrative Despite Modest Revenue Growth

InfuSystem Holdings (INFU) has wrapped up FY 2025 with Q4 revenue of US$36.2 million and basic EPS of US$0.10, capping a year in which trailing twelve month revenue reached US$143.4 million and EPS came in at US$0.32. The company has seen quarterly revenue move from US$33.8 million in Q4 2024 to US$36.5 million in Q3 2025 and US$36.2 million in Q4 2025, while basic EPS shifted from US$0.04 in Q4 2024 through a low of US$0.01 loss in Q1 2025 before landing between US$0.10 and US$0.12 over the...
NYSE:YOU
NYSE:YOUSoftware

Clear Secure (YOU) Margin Compression Tests Bullish Earnings Narratives After FY 2025 Results

Clear Secure FY 2025 earnings snapshot Clear Secure (YOU) has wrapped up FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.31, alongside trailing 12 month revenue of US$900.8 million and EPS of US$1.14 that frame the latest print in a broader earnings context. Over recent periods the company has seen quarterly revenue move from US$198.4 million in Q3 2024 to US$240.8 million in Q4 2025, while basic EPS has shifted from US$0.25 to US$0.31 across the same span...
NasdaqGS:AMPH
NasdaqGS:AMPHPharmaceuticals

FDA COPD Generic Exclusivity Might Change The Case For Investing In Amphastar Pharmaceuticals (AMPH)

In February 2026, Amphastar Pharmaceuticals received U.S. FDA approval for its Ipratropium Bromide HFA Inhalation Aerosol as a generic equivalent to Boehringer Ingelheim's Atrovent HFA, including 180 days of marketing exclusivity for COPD maintenance treatment. This short period of exclusivity offers Amphastar a time-limited window to build presence in the inhaled COPD market while supporting its broader mix of generic and proprietary products. Next, we’ll examine how the 180-day exclusivity...
NYSE:LTH
NYSE:LTHHospitality

Life Time Group Holdings (LTH) Margin Jump Tests Bullish Profitability Narratives

Life Time Group Holdings (LTH) closed out FY 2025 with Q4 revenue of US$745.1 million, basic EPS of US$0.56 and net income excluding extra items of US$123 million, set against a year in which trailing twelve month revenue reached US$3.0 billion, EPS was US$1.71 and net income was US$373.7 million. Over the past few quarters, the company has seen revenue move from US$663.3 million and EPS of US$0.18 in Q4 2024 to US$745.1 million and EPS of US$0.56 in Q4 2025. Trailing EPS stepped up from...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

UFP Technologies (UFPT) Earnings Growth Of 15.8% Tests Bearish Margin Concerns

UFP Technologies (UFPT) has wrapped up FY 2025 with Q4 revenue of US$148.9 million and basic EPS of US$2.28, framed by trailing twelve month revenue of US$602.8 million and EPS of US$8.87 that reflect earnings growth of 15.8% over the past year. The company has seen revenue move from US$504.4 million and EPS of US$7.69 on a trailing basis in Q4 2024 to US$602.8 million and EPS of US$8.87 by Q4 2025, which sets the scene for investors to weigh solid earnings expansion against a slightly softer...
NYSE:AOMR
NYSE:AOMRMortgage REITs

Angel Oak Mortgage REIT (AOMR) Quarterly EPS Swings Challenge Income Stability Narratives

Angel Oak Mortgage REIT (AOMR) has just posted its FY 2025 results, with Q4 total revenue of US$16.7 million and basic EPS of US$0.46, while trailing 12 month revenue came in at US$61.0 million and basic EPS at US$1.86, alongside reported earnings growth of 54% over the year. Over recent quarters the company has seen total revenue range from US$23.5 million and basic EPS of US$0.88 in Q1 2025, to US$5.9 million and basic EPS of US$0.03 in Q2, US$14.9 million and basic EPS of US$0.49 in Q3,...
NYSE:RRC
NYSE:RRCOil and Gas

Range Resources (RRC) Margin Expansion Reinforces Bullish Narratives After FY 2025 Earnings

Range Resources (RRC) has wrapped up FY 2025 with fourth quarter revenue of US$913.9 million and basic EPS of US$0.75, alongside net income excluding extra items of US$178.0 million, capping a year where trailing twelve month revenue reached US$3.1 billion and EPS came in at US$2.77. Over the past year the company has seen revenue move from US$2.4 billion to US$3.1 billion on a trailing basis, while net income excluding extra items has gone from US$265.0 million to US$658.0 million and basic...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Oddity Tech (ODD) Margin Compression Reinforces Bearish Narrative Despite FY 2025 EPS Growth

Recent Results Set Against a Shifting Earnings Outlook Oddity Tech (NasdaqGM:ODD) has wrapped up FY 2025 with fourth quarter revenue of US$152.7 million and basic EPS of US$0.10, alongside trailing twelve month revenue of US$809.8 million and EPS of US$1.95 that sit against a 9.1% year over year earnings increase and a net margin of 13.7%. Over the past year, the company has seen quarterly revenue move from US$123.6 million in Q4 2024 to US$268.1 million in Q1 2025, US$241.1 million in Q2,...
NasdaqGS:BLMN
NasdaqGS:BLMNHospitality

Bloomin' Brands (BLMN) Q4 EPS Loss Keeps Margin Concerns In Focus For Bulls And Bears

Bloomin' Brands FY 2025 earnings snapshot Bloomin' Brands (BLMN) has wrapped up FY 2025 with Q4 revenue of US$975.2 million and a basic EPS loss of US$0.14, as net income excluding extra items came in at a loss of US$12.2 million. Over the past few quarters, revenue has ranged from US$928.8 million to US$1.05 billion while EPS has swung from a profit of US$0.50 in Q1 to a loss of US$0.54 in Q3 and a smaller loss in Q4. This combination presents a mixed picture on earnings quality and...
NYSE:PSTL
NYSE:PSTLOffice REITs

Postal Realty Trust (PSTL) Earnings Margins Strengthen Supportive Bullish Lease Narrative

Postal Realty Trust (PSTL) has just wrapped up FY 2025 with fourth quarter revenue of US$26.0 million and basic EPS of US$0.25, alongside trailing 12 month revenue of US$95.8 million and basic EPS of US$0.58 that frame the latest numbers in a fuller earnings picture. Over the past few reporting periods, the company has seen revenue move from US$21.4 million in Q4 2024 to US$26.0 million in Q4 2025, while quarterly basic EPS shifted from US$0.17 to US$0.25, setting up this result against a...
NYSE:DRI
NYSE:DRIHospitality

Darden Restaurants Earns Quality Screen Spot With Solid Valuation Support

Darden Restaurants (NYSE:DRI) has been recognized for strong operational performance and quality metrics after passing a respected quality investing screen. The recognition highlights the company’s financial discipline and effective management, drawing fresh attention from long term investors focused on business quality. Darden Restaurants, trading at $212.06, is coming off a stretch of steady share performance that may catch your eye if you track longer time frames. The stock is up 13.3%...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Biologics (ABCL) Q4 Loss Narrows To US$0.03 EPS And Tests Bearish Narratives

AbCellera Biologics (ABCL) closed out FY 2025 with Q4 revenue of US$44.9 million and a basic EPS loss of US$0.03, alongside trailing 12 month revenue of US$75.1 million and a full year basic EPS loss of US$0.49, providing a snapshot of a business still investing heavily ahead of profitability. Over the past few quarters, the company reported revenue of US$4.2 million in Q1 2025, US$17.1 million in Q2, US$9.0 million in Q3 and US$44.9 million in Q4, while quarterly EPS losses moved from...
NYSE:AL
NYSE:ALTrade Distributors

Is It Too Late To Consider Air Lease (AL) After Strong Five Year Share Price Gains

If you are wondering whether Air Lease is still offering value at its current share price, this article will walk through what the numbers actually say about the stock. With the share price at US$64.85 and returns of 0.1% over 7 days, 0.7% over 30 days, 1.1% year to date, 36.8% over 1 year, 57.7% over 3 years and 50.1% over 5 years, many investors are asking whether expectations and valuation are now in sync. Recent news on Air Lease has focused on its role in supplying aircraft to airlines...
NYSE:AII
NYSE:AIIInsurance

American Integrity Insurance Group (AII) Margin Expansion Challenges Bearish Earnings Narratives

American Integrity Insurance Group closed FY 2025 with fourth quarter revenue of US$68.1 million and basic EPS of US$1.07, rounding out a twelve month stretch that produced total revenue of US$276.5 million and basic EPS of US$5.65. Over the past year, the company has seen revenue move from US$204.4 million to US$276.5 million and basic EPS adjust from US$309.45 to US$5.65 on a trailing twelve month basis, giving investors a detailed view of how the top and bottom lines have evolved. With net...
NYSE:GIC
NYSE:GICTrade Distributors

Global Industrial (GIC) Earnings Growth And 5.2% Margin Challenge Long Term Skepticism

Global Industrial (GIC) has just wrapped up FY 2025 with fourth quarter revenue of US$345.6 million and basic EPS of US$0.38, capping a trailing twelve month period where earnings grew 19.4% and net margin reached 5.2%. The company has seen revenue move from US$302.3 million and EPS of US$0.27 in Q4 2024 to US$345.6 million and EPS of US$0.38 in Q4 2025, while trailing twelve month net income, excluding extraordinary items, stood at US$72 million on US$1.4 billion of revenue. With earnings...
NYSE:SEI
NYSE:SEIEnergy Services

Solaris Energy Infrastructure (SEI) Quarterly Loss Tests Bullish High‑Growth Narrative

Solaris Energy Infrastructure (SEI) has capped FY 2025 with Q4 revenue of US$179.7 million and a small EPS loss of US$0.04, set against a trailing 12 month EPS of US$0.69 on revenue of US$622.2 million and earnings growth of 95.8% over the past year. Over recent periods the company has seen revenue lift from US$96.3 million in Q4 FY 2024 to US$179.7 million in Q4 FY 2025. Quarterly EPS moved from US$0.20 to US$0.32 and US$0.30 in Q2 and Q3 FY 2025 before slipping to a modest loss in Q4,...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Showcases Robotics And Smart Implants At AAOS 2026 Event

Zimmer Biomet Holdings (NYSE:ZBH) plans to showcase advanced orthopedic technologies at AAOS 2026. The lineup includes FDA-cleared robotics, AI-supported navigation systems, smart implants, and fresh clinical data. Chief Movement Officer Arnold Schwarzenegger is scheduled to appear as a guest speaker at the event. Zimmer Biomet is a major player in musculoskeletal healthcare, with a portfolio that spans joint replacement, sports medicine, and related technologies. The AAOS 2026 announcement...